Cargando…
Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights
Patients with asthma are somewhat protected from COVID-19 complications compared to COPD. This may be due to variability in viral attachment protein, ICS use, smoking/vaping status, a skewed inflammatory pattern, and dysregulated endocytic machinery. https://bit.ly/3qOcyNb
Autores principales: | Wark, Peter A.B., Pathinayake, Prabuddha S., Eapen, Mathew Suji, Sohal, Sukhwinder Singh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287734/ https://www.ncbi.nlm.nih.gov/pubmed/34244320 http://dx.doi.org/10.1183/13993003.00920-2021 |
Ejemplares similares
-
COVID-19 and vaping: risk for increased susceptibility to SARS-CoV-2 infection?
por: McAlinden, Kielan Darcy, et al.
Publicado: (2020) -
Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration?
por: Eapen, Mathew Suji, et al.
Publicado: (2020) -
Differential airway remodeling changes were observed in patients with asthma COPD overlap compared to patients with asthma and COPD alone
por: Dey, Surajit, et al.
Publicado: (2022) -
Airway inflammatory changes in the lungs of patients with asthma-COPD overlap (ACO): a bronchoscopy endobronchial biopsy study
por: Dey, Surajit, et al.
Publicado: (2023) -
Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects
por: Jacobs, Merel, et al.
Publicado: (2020)